رجوع
نطاق اليوم
KWD 468.36
KWD 476.13
نطاق 52 أسبوعًا
KWD 425.00
KWD 603.88
حجم التداول
1,170,235
متوسط 50 يوم / 200 يوم
KWD 505.85
/
KWD 509.44
الإغلاق السابق
KWD 478.04
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 58.7 | 0.3 |
| P/B | 9.4 | 2.9 |
| ROE % | 16.7 | 3.7 |
| Net Margin % | 28.4 | 3.8 |
| Rev Growth 5Y % | 15.2 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 638.750
+35.4%
Low: KWD 550.000
High: KWD 750.000
مكرر الربحية المستقبلي
47.6
ربحية السهم المستقبلية
KWD 10.046
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
12 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 16.547
KWD 15.596 – KWD 17.748
|
19 B | 5 |
| FY2029 |
KWD 15.130
KWD 14.261 – KWD 16.229
|
17 B | 2 |
| FY2028 |
KWD 13.223
KWD 12.292 – KWD 14.320
|
15 B | 7 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 |
Samath Jamie
EVP & CFO & Enterprise Technol
|
other | 28,766 | — | — |
| Jan 29, 2026 |
Leonard Keith R
Director
|
other | 369 | — | — |
| Dec 15, 2025 |
Brosius Mark
See Remarks
|
sell | 464 | KWD 548.490 | KWD 254,499 |
| Dec 12, 2025 |
Brosius Mark
See Remarks
|
sell | 312 | KWD 547.360 | KWD 170,776 |
| Dec 10, 2025 |
Curet Myriam
EVP & Chief Medical Officer
|
other | 208 | KWD 229.390 | — |
| Dec 10, 2025 |
Curet Myriam
EVP & Chief Medical Officer
|
sell | 104 | KWD 559.900 | KWD 58,230 |
| Nov 12, 2025 |
BARRATT CRAIG H
Director
|
other | 1,500 | KWD 71.323 | — |
| Nov 12, 2025 |
BARRATT CRAIG H
Director
|
sell | 750 | KWD 580.000 | KWD 435,000 |
| Nov 12, 2025 |
Leonard Keith R
Director
|
other | 1,606 | — | — |
| Sep 4, 2025 |
Ladd Amy L
Director
|
sell | 335 | KWD 440.690 | KWD 147,631 |
| Sep 3, 2025 |
Ladd Amy L
Director
|
sell | 336 | KWD 470.110 | KWD 157,957 |
| Jun 4, 2025 |
Rosa David J.
President
|
other | 851 | — | — |
| May 16, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 20 | KWD 563.810 | KWD 11,276 |
| May 15, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | KWD 560.000 | KWD 12,320 |
| May 14, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | KWD 563.000 | KWD 12,386 |
| May 13, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | KWD 561.670 | KWD 12,357 |
| May 12, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 22 | KWD 551.970 | KWD 12,143 |
| May 1, 2025 |
Leonard Keith R
Director
|
grant | 531 | — | — |
| May 1, 2025 |
NACHTSHEIM JAMI K
Director
|
other | 4,800 | KWD 90.494 | — |
| May 1, 2025 |
NACHTSHEIM JAMI K
Director
|
sell | 2,400 | KWD 520.000 | KWD 1,248,000 |
النقاط الرئيسية
Revenue grew 15.22% annually over 5 years — strong growth
Earnings grew 22.97% over the past year
ROE of 16.67% — decent returns on equity
Net margin of 28.38% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 2.49B in free cash flow
النمو
Revenue Growth (5Y)
15.22%
Revenue (1Y)20.51%
Earnings (1Y)22.97%
FCF Growth (3Y)82.28%
الجودة
Return on Equity
16.67%
ROIC12.19%
Net Margin28.38%
Op. Margin29.27%
الأمان
Debt / Equity
0.02
Current Ratio4.87
Interest Coverage0.00
التقييم
P/E Ratio
58.68
P/B Ratio9.40
EV/EBITDA55.86
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.51% | Revenue Growth (3Y) | 18.86% |
| Earnings Growth (1Y) | 22.97% | Earnings Growth (3Y) | 26.03% |
| Revenue Growth (5Y) | 15.22% | Earnings Growth (5Y) | 13.77% |
| Profitability | |||
| Revenue (TTM) | 10.06B | Net Income (TTM) | 2.86B |
| ROE | 16.67% | ROA | 13.84% |
| Gross Margin | 66.00% | Operating Margin | 29.27% |
| Net Margin | 28.38% | Free Cash Flow (TTM) | 2.49B |
| ROIC | 12.19% | FCF Growth (3Y) | 82.28% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 4.87 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 58.68 | P/B Ratio | 9.40 |
| P/S Ratio | 16.65 | PEG Ratio | 3.17 |
| EV/EBITDA | 55.86 | Dividend Yield | 0.00% |
| Market Cap | 167.59B | Enterprise Value | 164.52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B |
| Net Income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B |
| EPS (Diluted) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 |
| Gross Profit | 6.64B | 5.63B | 4.73B | 4.20B | 3.96B |
| Operating Income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20.63B | 18.84B | 15.44B | 12.97B | 13.56B |
| Total Liabilities | 2.69B | 2.31B | 2.04B | 1.86B | 1.60B |
| Shareholders' Equity | 17.82B | 16.43B | 13.31B | 11.04B | 11.95B |
| Total Debt | 302.80M | 146.00M | 0.0 | 0.0 | 87.00M |
| Cash & Equivalents | 3.37B | 2.03B | 2.75B | 1.58B | 1.29B |
| Current Assets | 9.78B | 7.11B | 7.89B | 6.25B | 5.84B |
| Current Liabilities | 2.01B | 1.75B | 1.66B | 1.42B | 1.15B |